Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Haemodynamic Effects of Nebivolol in Patients with Coronary Artery Disease

  • 6 Accesses

  • 1 Citations


Nebivolol is a novel β1-adrenoceptor blocking drug with an unusual haemodynamic profile unlike that of classical β-blockers. In dogs and in healthy volunteers, it decreases blood pressure and heart rate but improves left ventricular function. We studied 10 male patients with coronary artery disease and heart failure (mean ejection fraction 46%). A Swan-Ganz catheter was placed into the pulmonary artery and the mean blood pressure, heart rate, pulmonary artery pressure, pulmonary wedge pressure, right atrial pressure, cardiac output and stroke volume were measured at rest and on exertion before and after 7 days’ treatment with oral nebivolol 5 mg/day. Whereas the blood pressure and the heart rate decreased significantly, the pulmonary artery and wedge pressures and right atrial pressure and cardiac output did not change during treatment. The stroke volume increased significantly. The maintained cardiac output cannot be explained by any changes in pre- or afterload; instead, a positive inotropic mechanism may be the explanation.

This is a preview of subscription content, log in to check access.


  1. Alderman J, Grossman W. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?. Circulation 71: 854–857, 1985

  2. Braunwald E, Sonnenblick EH (Eds). Heart failure, pp. 1–13, Raven Press, New York, 1984

  3. Burkart F, Pfisterer M, Steinmann E. Wirkungen von Bisoprolol — im Vergleich zu Metoprolol und Bufuralol — auf die linksventrikuläre Hämodynamik in Ruhe und unter Belastung bei chronischer koronarer Herzkrankheit. Journal of Cardiovascular Pharmacology 8 (Suppl. 11): 89–93, 1986

  4. De Crée J, Geukens H, Cobo C, Verhaegen H. Subacute hemodynamic effects of nebivolol in man at rest and during exercise. Angiology 6: 440–448, 1987

  5. De Crée J, Geukens H, Leempoels J, Verhaegen H. Haemodynamic effects in man during exercise of a single oral dose of nebivolol (R 67 555), a new beta-1-adrenoceptor blocking agent: a comparative study with atenolol, pindolol and propranolol. Drug Development Research 8: 109–117, 1986

  6. Pauwels P, Gommeren W, Van Lommen G, Janssen P, Leysen J. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers. Molecular Pharmacology 34: 843–851, 1988

  7. Shanes JG. Beta-blockade — rational or irrational therapy for congestive heart failure?. Circulation 76: 971–973, 1987

  8. Stokholm KH, Lund JD, Trap-Jensen J. Immediate haemodynamic effects of atenolol, bopindolol and placebo: a double blind crossover study of the partial agonist activity of bopindolol. Current Opinion in Cardiology 3 (Suppl. 2): 89–91, 1988

  9. Van Bortel L, Schiffers P, Mooy J. Invasive hemodynamics of nebivolol in hypertensive patients. A preliminary report. International Symposium on Cardiovascular Disease and Beta-Adrenoceptor Function, Antwerp, Belgium, pp. 46–47, Oct 8, 1988

  10. Van de Water A, Xhonneaux R, Reneman R, Janssen P. Cardiovascular effects of dl-nebivolol and its enantiomers. A comparison with those of atenolol. European Journal of Pharmacology 156: 95–103, 1988

  11. Xhonneux R, de Reese R, Van Dael L, Reneman R. The blood pressure lowering effect of dl-nebivolol in spontaneously hypertensive rats — the potentiating action of 1-nebivolol and d-nebivolol and some other compounds. International Symposium on Cardiovascular Disease and Beta-Adrenoceptor Function, Antwerp, Belgium, pp. 16–17, Oct 8, 1988

Download references

Author information

Correspondence to Dr Stephan Brune.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brune, S., Tebbe, U., Schmidt, T. et al. Haemodynamic Effects of Nebivolol in Patients with Coronary Artery Disease. Drug Invest 3, 64–68 (1991). https://doi.org/10.1007/BF03258266

Download citation


  • Cardiac Output
  • Stroke Volume
  • Pulmonary Artery Pressure
  • Atrial Pressure
  • Nebivolol